.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Novartis
Fish and Richardson
Dow
Cerilliant
Merck
US Army
Queensland Health
Moodys
Cipla

Generated: November 22, 2017

DrugPatentWatch Database Preview

Calcium acetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for calcium acetate and what is the scope of calcium acetate patent protection?

Calcium acetate
is the generic ingredient in five branded drugs marketed by Cypress Pharm, Chartwell Rx, Heritage Pharms Inc, Invagen Pharms, Lupin Ltd, West-ward Pharms Int, Amneal Pharms, Fresenius Medcl, Paddock Llc, Nostrum Labs Inc, and Eci Pharms Llc, and is included in sixteen NDAs. There are five patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Calcium acetate has twenty-three patent family members in seventeen countries and eight supplementary protection certificates in five countries.

There are two hundred and seventy drug master file entries for calcium acetate. Thirty-four suppliers are listed for this compound.

Pharmacology for calcium acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Medcl
PHOSLO
calcium acetate
CAPSULE;ORAL021160-002Apr 2, 2001DISCNNoNo► Subscribe► Subscribe ► Subscribe
Fresenius Medcl
PHOSLO
calcium acetate
CAPSULE;ORAL021160-001Apr 2, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
CALCIUM ACETATE
calcium acetate
CAPSULE;ORAL077728-001Feb 26, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms
CALCIUM ACETATE
calcium acetate
CAPSULE;ORAL201658-001Oct 6, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Chartwell Rx
CALCIUM ACETATE
calcium acetate
CAPSULE;ORAL091312-001Jun 1, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Heritage Pharms Inc
CALCIUM ACETATE
calcium acetate
TABLET;ORAL202885-001Jan 22, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Heritage Pharms Inc
CALCIUM ACETATE
calcium acetate
CAPSULE;ORAL202315-001Jun 29, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Eci Pharms Llc
CALCIUM ACETATE
calcium acetate
CAPSULE;ORAL203298-001Jul 26, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Fresenius Medcl
PHOSLYRA
calcium acetate
SOLUTION;ORAL022581-001Apr 18, 2011RXYesYes► Subscribe► SubscribeY ► Subscribe
Paddock Llc
CALCIUM ACETATE
calcium acetate
TABLET;ORAL091561-001Apr 13, 2011ABRXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: calcium acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Fresenius Medcl
PHOSLO
calcium acetate
CAPSULE;ORAL021160-001Apr 2, 2001► Subscribe► Subscribe
Fresenius Medcl
PHOSLO
calcium acetate
TABLET;ORAL019976-001Dec 10, 1990► Subscribe► Subscribe
Fresenius Medcl
PHOSLO GELCAPS
calcium acetate
CAPSULE;ORAL021160-003Apr 2, 2001► Subscribe► Subscribe
Fresenius Medcl
PHOSLO
calcium acetate
CAPSULE;ORAL021160-002Apr 2, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: calcium acetate

Country Document Number Estimated Expiration
China104095838► Subscribe
Canada2658465► Subscribe
China101522021► Subscribe
Australia2007275606► Subscribe
Israel196584► Subscribe
South Korea101553719► Subscribe
Poland2048948► Subscribe
Russian Federation2463060► Subscribe
Japan5335674► Subscribe
Spain2382993► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: CALCIUM ACETATE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB03/033United Kingdom► SubscribePRODUCT NAME: ROSUVASTATIN OPTIONALLY IN THE FORM OF A NON-TOXIC PHARMACEUTICALLY ACCEPTABLE SALT, PARTICULARLY THE CALCIUM SALT.; REGISTERED: NL 26872 20021106; NL 26873 20021106; NL 26874 20021106; UK PL 17901/0201 20030321; UK PL 17901/0202 20030321; UK PL 17901/0203 20030321
/2008Austria► SubscribePRODUCT NAME: FOSAMPRENAVIR ALS FOSAMPRENAVIR-CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001 - EU/1/04/282/002 (MITTEILUNG VOM 14.07.2004) 20040713
2014 00050Denmark► SubscribePRODUCT NAME: EZETIMIBE AND ATORVASTATIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, INCLUDING ATORVASTATIN AS ATORVASTATIN CALCIUM TRIHYDRATE; REG. NO/DATE: DE/H/3895-3898/001-004/DC 20140910
2008006Lithuania► SubscribePRODUCT NAME: FOSAMPRENAVIR CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001-002 20040712
2008006,C0933372Lithuania► SubscribePRODUCT NAME: FOSAMPRENAVIR CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001-002 20040712
/1997Austria► SubscribePRODUCT NAME: ATORVASTATIN CALCIUM; NAT. REGISTRATION NO/DATE: 1-21926, 1-21927, 1-21928 19970411; FIRST REGISTRATION: GB PL 00018/0240 - PL 00018/0242 19961107
00125Netherlands► SubscribePRODUCT NAME: ROSUVASTATINUM, DESGEWENST IN DE VORM VAN EEN NIET-TOXISCH FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER HET CALCIUMZOUT; REGISTRATION NO/DATE: RVG 26872 - RVG 26874 20021106
C/GB08/018United Kingdom► SubscribePRODUCT NAME: FOSAMPRENAVIR CALCIUM: ((1S,2R)-3-(((4-AMINOPHENYL)SULFONYL)(2-METHYLPROPYL)AMINO)-1-(PHENYLMETHYL)-2(PHOSPHONOOXY)PROPYL)-CARBABAMIC ACID C-((3S)-TETRAHYDRO-3-FURANYL) ESTER CALCIUM SALT; REGISTERED: UK EU/1/04/282/001 20040712; UK EU/1/04/282/002 20040712
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Cipla
Boehringer Ingelheim
Dow
Cerilliant
Johnson and Johnson
Chinese Patent Office
Deloitte
US Army
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot